Drug withdrawal convulsions and drugs of ingredients of melatonin (a real world drug study)


Summary:

Drug withdrawal convulsions is found among people who take drugs with ingredients of melatonin, especially for people who are female, 10-19 old . This phase IV clinical study is created by eHealthMe based on reports of 54,270 people who have side effects when taking drugs with ingredients of melatonin from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Mel, Melatonin, Mlt, N-acetyl-5-methoxytryptamine, Pineal hormone.


On Jul, 28, 2026

54,270 people reported to have side effects when taking drugs with ingredients of melatonin.
Among them, 15 people (0.03%) have Drug withdrawal convulsions


What is Drug withdrawal convulsions?

Drug withdrawal convulsions is found to be associated with 150 drugs and 227 conditions by eHealthMe. Check the latest studies of Drug withdrawal convulsions.

Number of reports submitted per year:

Could drugs with ingredients of melatonin cause Drug withdrawal convulsions?

Gender of people who have Drug withdrawal convulsions when taking drugs with ingredients of melatonin *:

  • female: 86.67 %
  • male: 13.33 %

Age of people who have Drug withdrawal convulsions when taking drugs with ingredients of melatonin *:

  • 0-1: 0.0 %
  • 2-9: 14.29 %
  • 10-19: 28.57 %
  • 20-29: 21.43 %
  • 30-39: 14.29 %
  • 40-49: 0.0 %
  • 50-59: 21.43 %
  • 60+: 0.0 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 26.67%
  2. Pain: 3 people, 20.00%
  3. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 20.00%
  4. Intervertebral Disc Degeneration (spinal disc degeneration): 2 people, 13.33%
  5. Stress And Anxiety: 2 people, 13.33%
  6. Back Pain: 2 people, 13.33%
  7. Herniated Nucleus Pulposus (Slipped Disk): 2 people, 13.33%
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 13.33%
  9. Neck Pain: 2 people, 13.33%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 13.33%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Sabril: 6 people, 40.00%
  2. Vitamin D3: 5 people, 33.33%
  3. Metformin: 3 people, 20.00%
  4. Ativan: 3 people, 20.00%
  5. Tylenol: 3 people, 20.00%
  6. Zofran: 2 people, 13.33%
  7. Lamictal: 2 people, 13.33%
  8. Lyrica: 2 people, 13.33%
  9. Lasix: 2 people, 13.33%
  10. Duexis: 2 people, 13.33%

Other side effects people have besides Drug withdrawal convulsions *:

You may use this to check any potential undetected side effects.

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 40.00%
  2. Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 2 people, 13.33%
  3. Drug Dependence: 2 people, 13.33%
  4. Hyperhidrosis (abnormally increased sweating): 1 person, 6.67%
  5. Cuts And Puncture Wounds: 1 person, 6.67%
  6. Drug Ineffective: 1 person, 6.67%
  7. Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 1 person, 6.67%
  8. Fainting (loss of consciousness and postural tone): 1 person, 6.67%
  9. Fall: 1 person, 6.67%
  10. Fever: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of melatonin, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on melatonin. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: